Take Your Trading To The Next Level. Get Started Here!

Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold

May 2, 2024 Comments Off

The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.